Rufinamide (Compound)

Synonyms:Rufinamide, 106308-44-5, Banzel, Inovelon, 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, Cgp 33101, CGP-33101, RUF 331, 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide, Xilep, RUF-331, 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide, C10H8F2N4O, E-2080, E2080, E 2080, WFW942PR79, DTXSID1046506, 1H-1,2,3-Triazole-4-carboxamide, 1-[(2,6-difluorophenyl)methyl]-, NCGC00165883-02, 1H-1,2,3-Triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)-, DTXCID9026506, 170939-95-4, 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide, SMR000857122, CAS-106308-44-5, UNII-WFW942PR79, Rufinamide [USAN:INN:BAN], SYN111, SYN-111, CGP33101, Banzel (TN), MFCD00865314, Rufinamide (Banzel), CGP 33,101, RUFINAMIDE [MI], RUFINAMIDE [INN], RUFINAMIDE [JAN], RUFINAMIDE [USAN], RUFINAMIDE [VANDF], RUFINAMIDE [MART.], RUFINAMIDE [USP-RS], RUFINAMIDE [WHO-DD], Rufinamide (JAN/USP/INN), MLS001332513, MLS001332514, RUFINAMIDE [EMA EPAR], SCHEMBL230448, GTPL7470, CHEMBL1201754, RUFINAMIDE [ORANGE BOOK], CHEBI:134966, HMS2232M19, HMS3262O14, HMS3371A06, HMS3651O05, HMS3884G07, RUFINAMIDE [USP MONOGRAPH], BCP21828, HY-A0042, Tox21 112267, Tox21_112267, Tox21_500796, BDBM50515492, HB1039, s1256, AKOS005145897, Rufinamide, >=98% (HPLC), powder, Tox21_112267_1, AC-1429, CCG-222100, CS-1455, DB06201, LP00796, SB18904, SDCCGSBI-0633757.P001, NCGC00165883-01, NCGC00165883-03, NCGC00165883-04, NCGC00165883-11, NCGC00261481-01, AS-13861, FT-0656828, FT-0674479, R0143, SW219770-1, C71253, D05775, EN300-120881, AB00918347-05, AB00918347_06, A801414, Q408565, SR-01000842156, J-001568, SR-01000842156-4, 1-[(2,6-difluorophenyl)methyl]-4-triazolecarboxamide, F0001-2404, Z1532717444, 1-(2,6-Difluorobenzyl)-1H-1,2,3-triazol-4-carboxamide, Rufinamide, United States Pharmacopeia (USP) Reference Standard, 1-[[2,6-bis(fluoranyl)phenyl]methyl]-1,2,3-triazole-4-carboxamide

Pubchem:PUBCHEM:129228

Id:e5bde06d-50ea-5ced-b576-8224d0e2fe49

Description:nan